Loading data
MBRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Research and development expense | 15.89 m USD | 17.73 m USD | 19.49 m USD | 18.97 m USD | 14.42 m USD |
| Operating profit | -25.1 m USD | -26.64 m USD | -29.63 m USD | -30.64 m USD | -22.97 m USD |
| Profit before tax | -33.56 m USD | -26.05 m USD | — | — | — |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | 33.56 m USD | 26.05 m USD | 29.77 m USD | -29.03 m USD | -15.89 m USD |
| Net income attributable to common shareholders | -33.66 m USD | -26.05 m USD | — | — | — |
| Basic earnings per share | -28.42 USD/share | -189.14 USD/share | -15.07 USD/share | -15.22 USD/share | -0.59 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.